Childhood abuse and treatment response in patients with irritable bowel syndrome: a post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release

A double-blind, randomized, placebo-controlled trial of paroxetine controlled-release in irritable bowel syndrome.

The Leukoencephalomalacia and Porencephalia Changes in the Brain and the Potential Usefulness of Olanzapine Treatment

Desvenlafaxine, a serotonin-norepinephrine uptake inhibitor for major depressive disorder, neuropathic pain and the vasomotor symptoms associated with menopause

Long-term efficacy and safety of aripiprazole in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder: 26-week prospective study

Duloxetine: An emerging evidence for fibromyalgia

Pregabalin augmentation of antidepressants in patients with accident-related posttraumatic stress disorder: an open label pilot study

Additive effect between quinine oxidoreductase gene (NQO1: Pro187Ser) and manganese superoxide dismutase gene (MnSOD: Ala-9Val) polymorphisms on tardive dyskinesia in patients with schizophrenia

Taq1A polymorphism in the dopamine D2 receptor gene as a predictor of clinical response to aripiprazole

Does neurotropin-3 have a therapeutic implication in major depression?